Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 3 | 2018 | 65 | 1.070 |
Why?
|
| Status Epilepticus | 2 | 2018 | 20 | 1.070 |
Why?
|
| Critical Care | 2 | 2017 | 108 | 0.950 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2015 | 4 | 0.890 |
Why?
|
| Stroke | 5 | 2019 | 691 | 0.880 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2015 | 4 | 0.840 |
Why?
|
| Vasospasm, Intracranial | 2 | 2021 | 13 | 0.670 |
Why?
|
| Anticonvulsants | 2 | 2018 | 57 | 0.660 |
Why?
|
| Brain Ischemia | 2 | 2018 | 158 | 0.600 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 93 | 0.570 |
Why?
|
| Brain Infarction | 2 | 2018 | 10 | 0.570 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 34 | 0.530 |
Why?
|
| Nervous System Diseases | 2 | 2017 | 46 | 0.520 |
Why?
|
| Phenylephrine | 1 | 2017 | 34 | 0.510 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 25 | 0.500 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 62 | 0.500 |
Why?
|
| Registries | 1 | 2018 | 294 | 0.490 |
Why?
|
| Brain | 3 | 2021 | 966 | 0.460 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2015 | 4 | 0.460 |
Why?
|
| Leukocytosis | 1 | 2015 | 8 | 0.460 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 18 | 0.460 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2015 | 6 | 0.450 |
Why?
|
| Collateral Circulation | 1 | 2015 | 10 | 0.440 |
Why?
|
| Apnea | 1 | 2014 | 6 | 0.430 |
Why?
|
| Brain Death | 1 | 2014 | 23 | 0.430 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 59 | 0.430 |
Why?
|
| Cerebellar Diseases | 1 | 2014 | 4 | 0.430 |
Why?
|
| Cerebellum | 1 | 2014 | 25 | 0.430 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 10 | 0.400 |
Why?
|
| Epilepsy | 1 | 2015 | 79 | 0.400 |
Why?
|
| Odontoid Process | 1 | 2013 | 2 | 0.400 |
Why?
|
| Hematoma | 1 | 2013 | 26 | 0.390 |
Why?
|
| Spinal Fractures | 1 | 2013 | 37 | 0.390 |
Why?
|
| Humans | 16 | 2021 | 32284 | 0.360 |
Why?
|
| Retrospective Studies | 5 | 2018 | 3612 | 0.340 |
Why?
|
| Male | 7 | 2018 | 19434 | 0.240 |
Why?
|
| Aged | 5 | 2018 | 10257 | 0.240 |
Why?
|
| Hypotension | 2 | 2017 | 43 | 0.230 |
Why?
|
| Middle Aged | 6 | 2021 | 11843 | 0.200 |
Why?
|
| Female | 7 | 2021 | 19954 | 0.200 |
Why?
|
| Antacids | 1 | 2021 | 4 | 0.170 |
Why?
|
| Calcium Carbonate | 1 | 2021 | 8 | 0.170 |
Why?
|
| Hypercalcemia | 1 | 2021 | 12 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3896 | 0.160 |
Why?
|
| Time Factors | 2 | 2015 | 2196 | 0.150 |
Why?
|
| Vascular Resistance | 1 | 2019 | 32 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 34 | 0.150 |
Why?
|
| Cerebral Angiography | 2 | 2021 | 60 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3410 | 0.140 |
Why?
|
| Adult | 3 | 2015 | 9263 | 0.140 |
Why?
|
| Hypertension | 2 | 2015 | 983 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2018 | 75 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 97 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 27 | 0.130 |
Why?
|
| Disease Management | 1 | 2018 | 129 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2017 | 121 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2017 | 164 | 0.120 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2015 | 2 | 0.110 |
Why?
|
| Minnesota | 1 | 2015 | 19 | 0.110 |
Why?
|
| Spinal Puncture | 1 | 2015 | 22 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2015 | 46 | 0.110 |
Why?
|
| Unconsciousness | 1 | 2015 | 3 | 0.110 |
Why?
|
| Vomiting | 1 | 2015 | 20 | 0.110 |
Why?
|
| Immunosuppression | 1 | 2015 | 118 | 0.110 |
Why?
|
| Hypoxia, Brain | 1 | 2014 | 3 | 0.110 |
Why?
|
| Blood Gas Analysis | 1 | 2014 | 16 | 0.110 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2014 | 8 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 548 | 0.110 |
Why?
|
| Sella Turcica | 1 | 2014 | 1 | 0.110 |
Why?
|
| Sphenoid Sinus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 1211 | 0.110 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2014 | 5 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2014 | 75 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 33 | 0.100 |
Why?
|
| Stents | 1 | 2015 | 159 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 502 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2013 | 86 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 755 | 0.100 |
Why?
|
| Disease Progression | 1 | 2015 | 590 | 0.100 |
Why?
|
| Radiography | 1 | 2013 | 358 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 818 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2014 | 1840 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2238 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 906 | 0.070 |
Why?
|
| Risk Factors | 1 | 2015 | 3938 | 0.060 |
Why?
|
| Animals | 1 | 2018 | 8165 | 0.060 |
Why?
|
| Nimodipine | 1 | 2021 | 2 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 49 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 53 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 77 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 293 | 0.030 |
Why?
|